Lung cancer trials in Poland

In Poland 114 Also abroad 2733

114 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Where
Bydgoszcz, Lodz, Otwock, Prabuty, Tomaszow Mazowiecki
Age
18 years and over
People
540 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06203210 · EU 2023-509628-16-00
Phase 2Taking people
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
Where
Lublin, Poznan
Age
18 years and over
People
204 worldwide
Run by
Boehringer Ingelheim
See details and how to joinNCT05882058 · EU 2023-504247-13-00
Phase 1Taking people
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
Where
Gdansk, Olsztyn, Poznan
Age
18 years and over
People
320 worldwide
Run by
BioNTech SE
See details and how to joinNCT05142189 · EU 2023-509283-14-00
Phase 3Taking people
A Randomized, Double-Blind, Placebo-Controlled, MultiRegional Phase III Clinical Study of Toripalimab Alone or in Combination With Tifcemalimab (JS004/TAB004) as Consolidation Therapy in Patients With Limited-Stage Small Cell Lung Cancer Without Disease Progression Following Chemoradiotherapy
Where
Bialystok, Olsztyn, Poznan, Warsaw
Age
18 years and over
People
147 worldwide
Run by
Shanghai Junshi Biosciences Co. Ltd.
See details and how to join2023-507097-41-01
Phase 2Taking people
Study of pre- and post-surgery treatment with IPH5201 and durvalumab in participants with lung cancer (MATISSE)
Where
Bialystok, Prabuty, Warsaw
Age
18 years to 64 years
People
69 worldwide
Run by
Innate Pharma
See details and how to join2023-507778-42-00
Phase 1Taking people
Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)
Where
Gdansk, Lodz, Przemyśl
Age
18 years and over
People
220 worldwide
Run by
Amgen
See details and how to joinNCT06598306 · EU 2024-511838-12-00
Phase 2Taking people
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)
Where
Bialystok, Krąków, Lublin, Poznan, Prabuty, Warsaw
Age
18 years and over
People
70 worldwide
Run by
Innate Pharma
See details and how to joinNCT05742607
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Gdansk, Warsaw
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
No phaseTaking people
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
Where
Bialystok
Age
18 years and over
People
90
Run by
Medical University of Bialystok
See details and how to joinNCT07529145
Phase 1Taking people
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Where
Gdansk, Olsztyn, Warsaw
Age
18 years and over
People
304 worldwide
Run by
AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00
Phase 3Taking people
A Phase III Study With THIO + Cemiplimab vs Chemotherapy as 3rd Line Treatment in Advanced/Metastatic NSCLC
Where
Kielce, Lodz, Lublin, Olsztyn, Otwock, Poznan, Prabuty, Siedlce, Walbrzych, Warsaw
Age
18 years and over
People
300 worldwide
Run by
Maia Biotechnology
See details and how to joinNCT06908304 · EU 2024-520164-33-00
No phaseTaking people
Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer
Where
Lodz, Lublin
Age
18 years and over
People
165
Run by
Copernicus Memorial Hospital
See details and how to joinNCT06529081
No phaseTaking people
Comparison of 40% Glucose Solution and Autologous Blood Patch Pleurodesis for Postoperative Air Leak After Lung Resections
Where
Poznan
Age
18 years and over
People
200
Run by
Wielkopolskie Centrum Pulmonologii i Torakochirurgii
See details and how to joinNCT06936969
Phase 1Taking people
Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
Where
Gdansk, Otwock, Poznan, Warsaw
Age
18 years to 75 years
People
190 worldwide
Run by
Innovent Biologics (Suzhou) Co. Ltd.
See details and how to joinNCT06613009 · EU 2025-523972-21-00